Mast Therapeutics, Inc. (MSTX)

[stocker25]

The truth is nobody knows the outcome. It's very clear in the company website.

"Double blind study, which means that neither Mast, the physician investigators, nor the patients involved in the clinical trial know the outcome of the study. The EPIC study data will remain blinded to Mast, including to its management and employees, throughout the completion of the QA/QC process and database lock procedures."